Compounds inhibiting CD95 signaling for the treatment of pancreatic cancer

Assignee

• Deutsches Krebsforschungszentrum
• Ruprecht - Karls - Universität Heidelberg

Inventors

• Ana Martin-Vilalba (1 patents)
• Peter Herhaus (1 patents)
• Ignacio Sancho-Martinez (4 patents)
• Susanne Kleber (3 patents)
• Thilo Welsch (1 patents)

View full patent text on Google Patents →